Chronic Pain Management in Cancer Survivors
The rise in survivorship has increased chronic pain in the cancer pain population, the treatment of which has many fundamental differences when compared with treatment for acute and terminal cancer pain.
Pollack Discusses Ongoing Research for Patients With Refractory mCRC and Other Hard-to-Treat GI Malignancies
Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer